Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMC 271108)

Published in J Clin Microbiol on April 01, 1984

Authors

S C Hadler, B L Murphy, C A Schable, W L Heyward, D P Francis, M A Kane

Articles citing this

Transmission of hepatitis B virus from adopted Asian children to their American families. Am J Public Health (1988) 1.46

Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker. Eur J Clin Microbiol Infect Dis (2005) 1.00

Enzyme immunoassay for anti-hepatitis B core (HBc) immunoglobulin G1 and significance of low-level results in competitive assays for anti-HBc. J Clin Microbiol (1989) 0.99

Improved detection of hepatitis B virus surface antigen by a new rapid automated assay. J Clin Microbiol (1999) 0.99

Prevalences of and risk factors for biliary stones and gallbladder polyps in a large Chinese population. HPB (Oxford) (2012) 0.88

Improvement in the specificity of assays for detection of antibody to hepatitis B core antigen. J Clin Microbiol (1991) 0.85

Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen. J Clin Microbiol (1991) 0.84

Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection. World J Gastroenterol (2006) 0.79

Comparative evaluation of commercial enzyme immunoassay kits for detection of hepatitis B seromarkers. J Clin Microbiol (1987) 0.77

The frequency and significance of isolated hepatitis B core antibody and the suggested management of patients. CMAJ (2001) 0.77

Hepatitis B infection in a day school for mentally retarded students: transmission from students to staff. Am J Public Health (1987) 0.76

Outcomes Among Children Who Received a Kidney Transplant in the United States From a Hepatitis B Core Antibody-Positive Donor, 1995-2010. J Pediatric Infect Dis Soc (2015) 0.75

Exposure to hepatitis B: review of current concepts. Bull N Y Acad Med (1989) 0.75

Articles by these authors

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA (1990) 6.09

Male-to-female transmission of human immunodeficiency virus. JAMA (1987) 4.52

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med (1986) 4.51

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis (1985) 4.47

Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (1998) 4.19

Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). J Immunol Methods (1985) 3.91

The prevention of acquired immunodeficiency syndrome in the United States. An objective strategy for medicine, public health, business, and the community. JAMA (1987) 3.84

The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med (1982) 3.69

Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med (1988) 3.49

Identification of a human population infected with simian foamy viruses. Nat Med (1998) 3.47

Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA (1990) 3.41

Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ (2004) 3.39

Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA (1989) 3.39

The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol (1974) 3.38

Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis (1991) 3.29

Hepatitis B virus infection among children born in the United States to Southeast Asian refugees. N Engl J Med (1989) 3.28

Field testing and comparative evaluation of rapid, visually read screening assays for antibody to human immunodeficiency virus. Lancet (1989) 3.18

Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med (1980) 3.01

HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance Group. N Engl J Med (1992) 3.01

Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis (1982) 2.96

The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA (1996) 2.85

Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. The Sentinel Hospital Surveillance Group. N Engl J Med (1990) 2.73

Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol (1986) 2.65

Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med (1992) 2.63

Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med (1985) 2.62

Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart (2008) 2.51

Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus. Gastroenterology (1985) 2.49

Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. Science (1983) 2.48

Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group. Ann Intern Med (1993) 2.45

Pasteurella multocida. Infections after domestic animal bites and scratches. JAMA (1975) 2.45

Evidence of marked sexual behavior change associated with low HIV-1 seroconversion in 149 married couples with discordant HIV-1 serostatus: experience at an HIV counselling center in Zaire. AIDS (1991) 2.43

Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension. Eur Respir J (2009) 2.31

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 2.25

Measurement of the false positive rate in a screening program for human immunodeficiency virus infections. N Engl J Med (1988) 2.22

Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation (2000) 2.18

Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health (1985) 2.14

Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet (1986) 2.11

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) (1994) 2.09

Reporting of HIV-1 infection through the provision of essential services. J Acquir Immune Defic Syndr (1993) 2.00

Epidemiology of human immunodeficiency virus infection and acquired immunodeficiency syndrome. Am J Med (1989) 1.98

Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group. N Engl J Med (1990) 1.92

Performance characteristics of a rapid HIV antibody assay in a hospital with a high prevalence of HIV infection. CDC-Bronx-Lebanon HIV Serosurvey Team. Ann Intern Med (1996) 1.90

Measles herd immunity. The association of attack rates with immunization rates in preschool children. JAMA (1992) 1.85

Epidemiology and prevention of hepatitis A in travelers. JAMA (1994) 1.85

Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine (1989) 1.80

Fate of poliovirus in northern quahaugs. Proc Soc Exp Biol Med (1966) 1.80

Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS (2001) 1.80

Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. Am J Cardiol (2001) 1.79

Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J Acquir Immune Defic Syndr (1993) 1.79

Hepatitis in day care centers: epidemiology and prevention. Rev Infect Dis (1986) 1.78

Hepatitis A: report of a common-source outbreak with recovery of a possible etiologic agent. II. Laboratory studies. J Infect Dis (1975) 1.77

Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA (1989) 1.77

Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis (1991) 1.75

Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation (2001) 1.75

Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74

Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med (1972) 1.73

Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol (2001) 1.71

The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III. Ann Intern Med (1985) 1.71

Accuracy in ECG lead placement among technicians, nurses, general physicians and cardiologists. Int J Clin Pract (2007) 1.71

Infection of chimpanzees with lymphadenopathy-associated virus. Lancet (1984) 1.67

Risk factors for hepatitis A in day-care centers. J Infect Dis (1982) 1.66

Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Eur Heart J (2000) 1.66

The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol (1987) 1.66

Epidemic acquired immune deficiency syndrome: epidemiologic evidence for a transmissible agent. J Natl Cancer Inst (1983) 1.65

Experimental infection of chimpanzees with antihemophilic (factor VIII) materials: recovery of virus-like particles associated with non-A, non-B hepatitis. J Med Virol (1979) 1.64

Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA (1996) 1.64

Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am J Epidemiol (1988) 1.63

Occurrence of hepatitis A, B, and non-A/non-B in the United States. CDC sentinel county hepatitis study I. Am J Med (1984) 1.61

Hepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virus. Infect Immun (1975) 1.59

CT of blunt trauma bowel and mesenteric injury: typical findings and pitfalls in diagnosis. Radiographics (2001) 1.58

Rubella seropositivity in the United States, 1988-1994. Clin Infect Dis (2001) 1.57

Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. J Am Coll Surg (1995) 1.57

Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med (1990) 1.57

Letter: Infectivity of serum containing HBsAg and antibody to e antigen. Lancet (1976) 1.56

Immunoglobulin M-specific serologic testing in an outbreak of foodborne viral hepatitis, type A. Am J Epidemiol (1980) 1.55

Viral depuration of the Northern quahaug. Appl Microbiol (1967) 1.54

The transmission and outcome of hepatitis A, B, and non-A, non-B: a review. Epidemiol Rev (1979) 1.53

Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53

Viral pollution of shellfish. 1. Some basic facts of uptake. Proc Soc Exp Biol Med (1966) 1.53

Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection. Int J Cancer (1992) 1.51

Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis (1989) 1.51

Effect of immunoglobulin on hepatitis A in day-care centers. JAMA (1983) 1.51

Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells. J Biol Chem (1985) 1.50

High HIV-1 incidence in young women masked by stable overall seroprevalence among childbearing women in Kinshasa, Zaïre: estimating incidence from serial seroprevalence data. AIDS (1994) 1.50

Performance and cost-effectiveness of a dual rapid assay system for screening and confirmation of human immunodeficiency virus type 1 seropositivity. J Clin Microbiol (1990) 1.47

Transmission of hepatitis B virus from adopted Asian children to their American families. Am J Public Health (1988) 1.46

The public's health unprotected. Reversing a decade of underutilization of hepatitis B vaccine. JAMA (1995) 1.46

Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health care settings: a review of risk factors and guidelines for prevention. World Health Organization. Bull World Health Organ (1991) 1.45